Eli Lilly Stock Soars While Novo Nordisk Sinks-Why The Weight-Loss Leaders Are Headed In Opposite Directions

There's a growing divergence between the shares of rival weight-loss drugmakers Eli Lilly and Novo Nordisk. Eli Lilly's (LLY) stock jumped over 10% Wednesday on the company's stronger-than-expected earnings and rosy outlook. Meanwhile, Novo Nordisk ( ...Read more